Behjatolah Monzavi Karbassi
Sourced from institutional research profiles (UAMS TRI or ARA).
Associate Professor
Faculty Researcher
Pathology, College of Medicine
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Behjatolah Monzavi Karbassi is an Associate Professor in the Department of Pathology at the University of Arkansas for Medical Sciences. His research focuses on exploring therapeutic targets in cancer, with a specific emphasis on breast cancer. He has received federal funding from the NIH/National Cancer Institute for his work on "SR-A as a therapeutic target in breast cancer," a project for which he serves as Principal Investigator and which was awarded $178,819.
Dr. Karbassi's scholarly work includes publications on the role of specific genes in the multiple myeloma microenvironment and the potential of antibody polyspecificity for cancer immunotherapy. His research network includes collaborators from within the University of Arkansas for Medical Sciences, such as Brian Koss, David E. Mery, Yan Cheng, and Thomas Kieber‐Emmons. He maintains an active laboratory website to share his research activities.
Metrics
- Publications: 6
Selected Publications
-
Abstract 2908: SR-A antagonism remodels the myeloid population of tumor immune microenvironment, expands CD8-positive T cells, and enhances antitumor efficacy in vivo (2026)
-
The Role of CST6 in Immunosuppression in the Multiple Myeloma Microenvironment (2024)
-
Harnessing Antibody Polyspecificity for Cancer Immunotherapy (2022)
-
Abstract 1450: Tumor-associated glycans interact with macrophages through class-A scavenger receptor (2016)
-
Evaluating the immunogenicity of carbohydrate mimotopes and synthetic conjugates (2007)
-
Reduction of tumor growth and spontaneous metastasis through induction of carbohydrate cross-reactive apoptotic antibodies (2005)Cancer Research OpenAlex
Federal Grants 1 $178,819 total
Research Interests
My primary research interest is in developing immunotherapeutic strategies to potentiate the anti-cancer immune response by targeting immune suppression within the tumor microenvironment. Central to my approach is the investigation of tumor-associated glycans (TAGs) as therapeutic targets, with a particular emphasis on breast cancer.
Grants & Funding
As listed on this researcher's institutional profile. Federal awards with verified records are shown above.
- Mimotope Conversion of HIV-1 Carbohydrate Antigens NIH Co-Investigator
- Vaccination of High-Risk Breast Cancer patients with Carbohydrate Mimicking Peptides US Department of the Army Co-Investigator
- Ex vivo models of breast cancer for the development of novel drug combinations, a pilot study. Arkansas Breast Cancer Research Program Co-Investigator
- Role of scavenger receptor-A (SR-A) binding to tumor-associated glycans Arkansas Breast cancer Research program Co-Investigator
- Defining Tumor-Associated Glycans on Breast Cancer Cells that are Ligands for Macrophage SR-A UAMS Medical Research Endowment fund Principle Investigator
- Explant models and derived primary cell lines for the discovery and testing of novel therapies for breast cancer. Arkansas Breast Cancer Research Program. Co-Investigator
- Vaccination of Breast Cancer Patients with P10s-PADRE Winthrop P Rockefeller Cancer Institute Principle Investigator
- Immune Responses to a Carbohydrate Mimetic Peptide Vaccine UAMS research council, Development Enhancement Awards for Proposals Principle Investigator
- Immune monitoring of vaccinated breast cancer patients Arkansas Bioscience Institute, Principle Investigator
Collaborators
Researchers in the database who share publications
Similar Researchers
Based on overlapping research topics